Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

A randomized phase III study of gefitinib (IRESSATM) versus standard chemotherapy (gemcitabine plus cisplatin) as a first-line treatment for never-smokers with advanced or metastatic adenocarcinoma of the lung

Authors
Lee, Jin S.Park, KeunchilKim, Sang-WeLee, Dae HoKim, Heung TaeHan, Ji-YounYun, TakAhn, Myung-JuAhn, Jin SeokSuh, CheolwonLee, Jung-ShinHan, Jong HeeYu, Sun YoungLee, Jae WonJo, SookJung
Issue Date
9월-2009
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Citation
JOURNAL OF THORACIC ONCOLOGY, v.4, no.9, pp.S283 - S284
Indexed
SCIE
SCOPUS
Journal Title
JOURNAL OF THORACIC ONCOLOGY
Volume
4
Number
9
Start Page
S283
End Page
S284
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/119451
ISSN
1556-0864
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Political Science & Economics > Department of Statistics > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher LEE, JAE WON photo

LEE, JAE WON
정경대학 (통계학과)
Read more

Altmetrics

Total Views & Downloads

BROWSE